Upregulation and activation of CHOP/GADD153 and JNK have been detected in apoptotic MM cells that were treated with PIs, which is frequently associated with NF-κB modulation [78,79]; this makes it a therapeutic target for drug resistance. This evidence concerns the gene MAPK8 and Miyoshi myopathy.